HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV

Portillo-Romero, Alejandra Jalil; León‐Maldonado, Leith; Allen‐Leigh, Betania; Brown, Brandon; Magis, Carlos; García-Fuentes, Norma Beatríz; Salmerón, Jorge; Hurtado, Erika; Torres‐Ibarra, Leticia; Rivera‐Paredez, Berenice; Hernández‐López, Rubí; Yunes-Díaz, Elsa; Lazcano‐Ponce, Eduardo

doi:10.21149/10182

Cited by 8 publications

(5 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Human papilloma virus (HPV) infection, which is sexually transmitted to both males and females, is a global epidemic (1)(2)(3). Approximately 75% of sexually active individuals encounter HPV at some time in their lives (4).…”

Section: Introductionmentioning

confidence: 99%

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Özdemir¹,

Akkaya²,

Karaşahin³

2020

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

Human papilloma virus (HPV) vaccine is a proven method for preventing HPV-related cancers and genital warts, especially preventing cervical cancer. It is aimed to systematically review and synthesize conclusions in detail from community-based studies published in Turkey between 2009 and 2019, which evaluate the knowledge, awareness, attitude, and behaviors of individuals towards HPV and HPV vaccination. This systematic review is conducted based on the PRISMA reporting method and includes community-based, descriptive cross-sectional and cross-sectional studies published between 2009 and 2019. In this systematic review, 5132 studies from six databases were scanned in total. It was determined that there were 23 studies that met the eligibility criteria for this systematic review. In the reviewed studies, it was determined that the rate of "Hearing of HPV before" was 3.8% at the lowest and 57.0% at the highest, and the rate of "Hearing of HPV vaccine before" was 2.2% at the lowest and 74.7% at the highest. In the reviewed studies, it was reported that although parents' willingness to have their daughters vaccinated with HPV vaccine varied between 14.4% and 68.0%, their willingness to have their sons vaccinated with HPV vaccine varied between 11.0% and 62.0%. In addition, it was reported that the lowest rate of vaccination with HPV vaccine among participants was 0.3% at the lowest and 6.0% at the highest. Consequently, it is considered that conducting common, systematic, and continuous health education programs aimed at both sexes and including both parents, which will increase the knowledge and awareness on HPV and its vaccine, would provide positive attitudes, and will be effective in protecting against HPV-related cancers.

show abstract

Section: Introductionmentioning

confidence: 99%

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Özdemir¹,

Akkaya²,

Karaşahin³

2020

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

show abstract

“…This finding echoes what other studies have observed regarding high levels of HPV vaccine acceptance even in instances of low-level awareness and knowledge about HPV, cervical cancer or vaccination. [11][12][13] In Mexico, the high acceptability of the vaccine among women has also been documented, 14 however, the need to promote knowledge about the benefits of the vaccine is also recognized. 15 An additional recommendation that could be offered to women to increase acceptability is to spread the message that the vaccine not only helps them but also their partners in the future cancer prevention.…”

Section: Discussionmentioning

confidence: 99%

Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan study experience

León‐Maldonado

Cabral

Brown

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

There has been a noticeable shift in discussions about cervical cancer, moving from prevention to elimination. Interventions such as FASTER, human papillomavirus (HPV) vaccination and HPV screening are innovative intervention strategies which can be utilized to begin a path to elimination. To explore the feasibility of the FASTER strategy, an evaluation was carried out in eight primary health-care centers within the Tlalpan Health-Jurisdiction of Mexico City between March 2017 and August 2018. A mixed methods approach was used to evaluate three components: infrastructure, patient acceptability, and health-care professionals' perceptions. This included checklists of requirements for the infrastructure rollout of FASTER and interviews with women and health-care professionals. Nearly all (93%) of the 3,474 women aged 25-45 years accepted HPV vaccination as part of a combined vaccination and screening program. The main reason for acceptance was prevention, while having doubts about the vaccine's benefits was the main reason for refusal. Most of the 24 health-care professionals had a positive opinion toward HPV vaccination and identified the need to increase dissemination, inform the population clearly and concisely and currently extend the age range for vaccination. The evaluation of eight primary health-care centers showed they had the necessary infrastructure for the development of a joint HPV prevention strategy, but many centers required improvements to become more efficient. Together these findings suggest that although HPV vaccine acceptance was high, there is the need to increase education and awareness among potential vaccine recipients and health-care professionals to implement the FASTER strategy.

show abstract

“…Out of the 24 articles included in this study, 23 were cross-sectional studies [18][19][20][21][22][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41], and 1 was a cohort study [23]. A total of 14,466 participants were included.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Most of the questionnaires were administered face-to-face (21 out of 24), one was administered through an online survey, one was administered through phone call and finally one was administered through a combination of telephone/face-to-face questionnaire. Geographically, the studies were distributed as follows: 7 from Mexico [20,30,32,38,39,41], 5 from Puerto Rico [23-25, 35, 40], 5 from Argentina [18,19,21,22,29] [36,37], 1 from Peru [33], and 1 from Haiti [31]. The different studies evaluated the acceptance rate of HPV vaccine in multiple populations.…”

Section: Study Characteristicsmentioning

confidence: 99%

HPV vaccine acceptance in Latin America and the Caribbean: a systematic review and meta-analysis

Salazar-Valdivia,

Alarcon-Braga,

Estrada-Grossmann

et al. 2024

Discov Public Health

View full text Add to dashboard Cite

Human Papillomavirus (HPV) infection poses a significant health burden in Latin America and the Caribbean (LAC), leading to various conditions from benign to malignant, including cervical, anal, and oropharyngeal cancers. This systematic review encompassed 24 studies with a total of 14,466 participants, exploring HPV vaccine acceptance in the region. It was conducted using the following databases: PubMed, Scopus, Ovid Medline, and Web of Science. The review reveals an 84% prevalence of HPV vaccine acceptance in the LAC. Factors influencing acceptance include education, income levels, and vaccine safety concerns. Peru and Honduras exhibited the highest acceptance rates, while the coronavirus disease 2019 (COVID-19) pandemic contributed to declining acceptance post-2019. The importance of educational campaigns and healthcare recommendations in promoting vaccine acceptance is highlighted, along with the impact of reduced vaccination access during the pandemic. This study underscores the critical role of ongoing educational initiatives and accessible healthcare in maintaining high HPV vaccine acceptance rates in LAC. Addressing the reduced acceptance during the pandemic is pivotal for reinstating effective vaccination programs. Findings emphasize the need of sustained efforts to ensure widespread vaccine acceptance, thereby mitigating the burden of HPV-related diseases in the region.

show abstract

HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV

Cited by 8 publications

References 56 publications

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Analysis of community-based studies related with knowledge, awareness, attitude, and behaviors towards HPV and HPV vaccine published in Turkey: A systematic review

Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan study experience

HPV vaccine acceptance in Latin America and the Caribbean: a systematic review and meta-analysis

Contact Info

Product

Resources

About